Loading clinical trials...
Loading clinical trials...
The goal of the project is to identify a molecular signature of tumor stroma from "normal" adjacent breast tissue obtained prospectively at the time of breast conserving surgery before and after recei...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Columbia University
NCT06681064 · Breast Cancer, Triple Negative Breast Cancer, and more
NCT05005403 · Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, and more
NCT06547840 · Advanced Ovarian Cancer, Platinum-resistant Ovarian Cancer, and more
NCT06649331 · Advanced Breast Cancer, Metastatic Breast Cancer, and more
NCT07029399 · HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC), and more
Columbia University Irving Medical Center
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions